Ghana’s Pharmacovigilance Experience
| dc.creator | Wang, Huihui | |
| dc.creator | Darko, Delese Mimi | |
| dc.creator | Figueras Sune, Albert | |
| dc.creator | Marquez, Patricio V. | |
| dc.creator | Kumwenda, James | |
| dc.date | 2023-09-21T17:09:40Z | |
| dc.date | 2023-09-21T17:09:40Z | |
| dc.date | 2023-09-21 | |
| dc.date.accessioned | 2026-07-01T00:34:12Z | |
| dc.description | The objective of this report is to examine the development of pharmacovigilance (PV) in Ghana and illustrate the role it plays in the health system, and more recently, during the COVID-19 emergency response. It concludes by offering some relevant lessons for building PV capacity in other low-and middle-income countries. | |
| dc.format | application/pdf | |
| dc.format | text/plain | |
| dc.identifier | http://documents.worldbank.org/curated/en/099091523152513662/P1746150a470ce0580ba2101638d49a53e7 | |
| dc.identifier | https://openknowledge.worldbank.org/handle/10986/40382 | |
| dc.identifier | 10.1596/40382 | |
| dc.identifier.uri | http://hdl.handle.net/123456789/406345 | |
| dc.language | English | |
| dc.language | en_US | |
| dc.publisher | Washington, DC: World Bank | |
| dc.relation | Pharmacovigilance and Essential Public Health Services Series | |
| dc.rights | CC BY-NC 3.0 IGO | |
| dc.rights | https://creativecommons.org/licenses/by-nc/3.0/igo | |
| dc.rights | World Bank | |
| dc.subject | PHARMACOVIGILANCE | |
| dc.subject | HEALTH SECTOR FUNDING | |
| dc.subject | FDA | |
| dc.subject | SAFETY MONITORING | |
| dc.title | Ghana’s Pharmacovigilance Experience | |
| dc.title | From Vertical Program Activity to Nationwide System | |
| dc.type | Report |